3D Global Biotech Inc. (6808.TWO)
TWD 51.2
(-7.25%)
TWD 51.2
(-7.25%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -11.43 Million TWD | -1035.92% |
| 2022 | 1.22 Million TWD | 30.7% |
| 2021 | 935 Thousand TWD | -92.43% |
| 2020 | 12.35 Million TWD | 1139.65% |
| 2019 | -1.18 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -66.41 Million TWD | -480.66% |
| 2024 Q2 | -66.41 Million TWD | 0.0% |
| 2023 FY | -11.43 Million TWD | -1035.92% |
| 2023 Q1 | -9.99 Million TWD | -917.51% |
| 2023 Q2 | -3.53 Million TWD | 64.62% |
| 2023 Q3 | -17.73 Million TWD | -401.81% |
| 2023 Q4 | -11.43 Million TWD | 35.51% |
| 2022 Q4 | 1.22 Million TWD | 123.72% |
| 2022 Q3 | -5.15 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 95.671% |
| Level Biotechnology Inc. | -453.9 Million TWD | 97.48% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 90.514% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 94.177% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 102.288% |
| GlycoNex Incorporation | -148.56 Million TWD | 92.302% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 128.404% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 108.288% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 95.644% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 137.403% |
| Visgeneer Inc. | 31.28 Million TWD | 136.559% |
| Mycenax Biotech Inc. | 207 Million TWD | 105.525% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 98.32% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 91.481% |
| Neith Corporation | -150.31 Million TWD | 92.391% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 101.84% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 80.164% |
| Enimmune corporation | -314.15 Million TWD | 96.359% |
| TaiRx, Inc. | -147.86 Million TWD | 92.265% |
| EirGenix Inc. | -4.58 Billion TWD | 99.751% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 86.507% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 109.462% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 99.645% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 96.397% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | 42.275% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 135.955% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 122.534% |
| RBC Bioscience Corporation | 422.18 Million TWD | 102.709% |
| BiOptic Inc. | 12.59 Million TWD | 190.828% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 98.789% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 88.73% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 93.076% |
| VBI | -25.31 Million TWD | 54.823% |
| CHO Pharma, Inc. | -203.79 Million TWD | 94.388% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 85.155% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 103.632% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 82.219% |
| NaviFUS Corp. | -123.12 Million TWD | 90.711% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 115.445% |
| Sinew Pharma Inc. | -160.34 Million TWD | 92.867% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 95.272% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 96.61% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 97.228% |
| AP Biosciences Inc | -196.52 Million TWD | 94.18% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 101.661% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 98.622% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 100.843% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 97.243% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 94.537% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 92.05% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 96.54% |
| TCI GENE Inc. | -689.25 Million TWD | 98.341% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 90.384% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 99.126% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 155.837% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 88.773% |
| PharmaEngine, Inc. | -860.8 Million TWD | 98.671% |
| Savior Lifetec Corporation | -812.54 Million TWD | 98.592% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 96.187% |
| OBI Pharma, Inc. | -398.22 Million TWD | 97.128% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 96.87% |
| Acepodia, Inc. | -6.02 Billion TWD | 99.81% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 99.664% |